Diagnostic utility of nailfold capillaroscopy

APLAR Journal of Rheumatology

Volumn 10, Issue 4, 2007, Pages 275-279

  Roberts Thomson, Peter J ^a   Cox, S R ^a   Walker, J G ^b   Dugar, M ^a   Ahern, M J ^a   Smith, M D ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diagnostic utility; Nail fold bleeds; Nail fold capillaroscopy; Scleroderma; Systemics clerosis

Indexed keywords

ADULT; ANTISYNTHETASE SYNDROME; ARTICLE; BLEEDING; CAPILLAROSCOPY; DERMATOMYOSITIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; MICROSCOPIC ANATOMY; NAIL BED; NAILFOLD CAPILLAROSCOPY; PREDICTION; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; RAYNAUD PHENOMENON; SCLERODERMA; SENSITIVITY AND SPECIFICITY; SYSTEMIC SCLEROSIS;

EID: 36749021713     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2007.00306.x     Document Type: Article

References (17)

1. Carpentier PH, Maricq HR (1990) Microvasculature in systemic sclerosis. Rheum Dis Clin North Am 16, 76-96.
2. Brown GE, O'Leary PA (1924) Skin capillaries in scleroderma. Arch Int Med 42, 72-88.
3. Maricq HR, Maize JC (1982) Nailfold capillary abnormalities. Clin Rheum Dis 8, 455-78.
4. Cutolo M, Pizzorni C, Sulli A (2005) Capillaroscopy. Best Pract Res Clin Rheumatol 19, 437-52.
5. Roberts-Thomson PJ, Jones M, Hakendorf P, et al. (2001) Scleroderma in South Australia: Epidemiological observations of possible pathogenic significance. Intern Med J 31, 220-9.
6. Spencer-Green G (1998) Outcomes in primary Raynaud's phenomenon: A meta-analysis of the frequency, rates and predictors of transition to secondary diseases. Arch Intern Med 158, 595-600.
7. Luggen M, Bellhorn L, Evans T, et al. (1995) The evolution of Raynaud's phenomenon: A long-term prospective study. J Rheumatol 22, 2226-32.
8. Pavlov-Dolijanovic S, Damjanov N, Ostojic P, et al. (2006) The prognostic value of nailfold capillary changes for the development of connective tissue disease in children and adolescents with primary Raynaud phenomenon: A follow-up study of 250 patients. Pediatr Dermatol 23, 437-42.
9. ARA Committee (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 23, 581-90.
10. Lonzetti LS, Joyal F, Raynauld JP, et al. (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44, 735-6.
11. Nadashkevich N, Davis P, Fritzler MJ (2004) A proposal of criteria for the classification of systemic sclerosis. Med Sci Monit 10, CR615-21.
12. LeRoy EC, Medsger TA Jr (2001) Criteria for the classification of early systemic sclerosis. J Rheumatol 28, 1573-6.
13. Maricq HR, Valter I (2004) A working classification of scleroderma spectrum disorders: A proposal and the results of testing on a sample of patients. Clin Exp Rheumatol 22 (Suppl. 33), S5-13.
14. Chandran G, Simmons L, Cheng G, et al. (1996) The abnormalities of nailfold capillaries in scleroderma as assessed by video image analysis and photomicroscopy. Asian Pacific J Allergy Immunol 14, 81-5.
15. Baron M, Bell M, Bookman A, et al. (2006) Office capillaroscopy in systemic sclerosis. Clin Rheumatol Dec 9; [Epub].
16. Sato S, Takehara K, Soma Y, Tsuchida T, Ishibashi Y (1993) Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders. J Am Acad Dermatol 28, 198-203.
17. Cutolo M, Grassi W, Cerinic MM (2003) Raynaud's phenomenon and the role of capillaroscopy. Arthritis Rheum 48, 3023-30.